Key result
Total red ginseng ginsenosides lower triglycerides ~42% and ameliorate hepatic steatosis in diabetic rats.
Why the study?
This study aims to clarify the material basis of total ginsenosides of red ginseng (RGW) and verify its activity in treating lipid metabolism disorders caused by T2DM.
Does red ginseng (RGW) improve lipid metabolism in preclinical models of Type 2 Diabetes Mellitus?
Population
Fatty degenerated HepG2 cells and rats
Comparison
RGW treatment vs not specified
Design
Preclinical laboratory study
Authors
Loading...
RGW activity in cell models warrants no clinical use yet; leaves open translation to T2DM patients pending rigorous trials.
Does red ginseng (RGW) improve lipid metabolism in preclinical models of Type 2 Diabetes Mellitus?
Absolute Event Rate: 1.64% vs 2.83%
p-value: p=<0.05
Red ginseng extract attenuates lipid deposition in vitro and alters short-chain fatty acid profiles in vivo, suggesting potential benefits for lipid metabolism in Type 2 Diabetes Mellitus.
Huang et al. (2022) studied Type 2 Diabetes Mellitus (n=60). Total ginsenosides of red ginseng (RGW) vs. Distilled water (DM control) was evaluated on Serum triglyceride (TG) levels (mmol/ml) (p=<0.05). Total ginsenosides of red ginseng significantly reduced fasting blood glucose, triglycerides, and total cholesterol levels, and ameliorated hepatic steatosis in a rat model of type 2 diabetes mellitus.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: